)
)
Generation Bio Investor Relations Material
Latest events
Study Result
Generation Bio
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Generation Bio Co
Access all reports
Generation Bio Co. is a biotechnology company focused on the development of genetic medicines to treat both rare and prevalent diseases. Leveraging its proprietary platform, the company is working on a range of therapies aimed at addressing conditions affecting the liver, retina, skeletal muscle, central nervous system, and oncology. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the Nasdaq.
Key slides for Generation Bio Co
TD Cowen 44th Annual Health Care Conference 2024
Generation Bio Co
TD Cowen Genetic Medicines & RNA Summit
Generation Bio Co
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
GBIO
Country
🇺🇸 United States